Deal activity by volume related to cybersecurity increased by 40% year-on-year in 2023 in the mining industry

A​​​​​​​nalysis of the key themes driving deal activity reveals that cybersecurity accounted for 25 mining deals between 2019 and 2023, worth a total value of $1,754m, according to GlobalData’s Deals database covering mergers and acquisitions, private equity, venture financing, equity offerings and partnerships.  

The $107m acquisition of 11% stake in Red 5 by Silver Lake Resources was the largest disclosed deal in 2023, while the $1.2bn acquisition of 100% stake in ETQ by Hexagon was the largest disclosed deal in 2022.  

In volume terms, cybersecurity related deal activity increased by 40% year-on-year in 2023 and by 150% year-on-year in 2022.

In drug discovery and development, cloud computing allows for secure R&D collaborations between research teams. It simplifies data transfer from laboratory equipment and can enable scientists to analyse results and generate outcomes faster. There are many software-as-a-service (SaaS) solutions to accelerate and improve drug discovery and development processes. 

Pharma companies either use a vendor’s drug discovery and development SaaS solutions or develop software in partnership with a cloud vendor. Examples of cloud computing in drug discovery and development range from bioinformatic and Covid-19 vaccine platforms to cloud-operated remote R&D laboratories.